Home » US Legislation Aims to Globalize FDA Inspection Program
US Legislation Aims to Globalize FDA Inspection Program
February 17, 2009
U.S. Reps. John Dingell (D-Mich.) and Bart Stupak (D-Mich.) introduced a globalization bill last month mandating that the Food and Drug Administration (FDA) inspect drug and device plants in the U.S. and abroad every two years unless the agency decides a facility’s record requires fewer reviews.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor